Isomorphic Labs explores new funding at a valuation of at least $40 billion

The Alphabet company uses artificial intelligence to discover drugs and is in early fundraising discussions, according to Bloomberg. It hopes new investment will accelerate drug development, Semafor reports. RuntimeWire, citing Bloomberg, says the valuation could reach $50 billion, although the terms could still change.

• According to RuntimeWire, the talks come five months after a $2.1 billion funding round.

Covered by 4 publishers within 18 hours of the first report.

• Bloomberg: Isomorphic Labs Seeks Funding at Valuation of $40 Billion

Reporting4

BL Bloomberg Alphabet’s Isomorphic Labs in Funding Talks for at Least $40 Billion Value · Natasha Mascarenhas, Rebecca Torrence, Ed Ludlow and Mark Bergen 12:00 AM

RTW RuntimeWire Isomorphic Labs talks $40B valuation five months after $2.1B round · RuntimeWire Staff 1:48 AM

SM Semafor Alphabet’s biolab in funding talks at $40B valuation · Jeronimo Gonzalez 7:08 AM

SA SiliconANGLE Alphabet spinoff Isomorphic Labs reportedly raising funding at up to $50B valuation · Maria Deutscher 5:55 PM

Related

CBS Google Cloud introduces Gemini agent for tasks across workplace apps October 8

AH Claude adds integration with Google Docs, Sheets and Slides October 7

UAI Anthropic introduces Claude Haiku 5.5 with lower running costs October 7

TNW Google makes SynthID Detector publicly available worldwide October 7

Topics Google